It does not matter about who is the CEO. Instead, it's the RS sales model that should have been left behind, in the last century.
As for the RS products, well, I used to distribute the Pronex device directly from the manufacturer back in the 90s, and the reimbursement from insurers left little room for profit.
The RS4i can only be sold in the WC and PI markets, as PPO insurers consider it to be 'investigational or experimental.' Their TENS units are just like those available all over the internet for far less, and Bledsoe has a wider and better variety of braces.
It's time to move on........
